Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.
Press releases published on March 13, 2025

Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
Company Achieves Key Clinical Milestone with more than 20 Patients Enrolled in Weekly Dosing Cohort of Phase 1 Trial of Decoy20 Pharmacodynamic immune activation biomarker and pharmacokinetics profiles in initial data sets appear to meet or exceed initial …

MeiraGTx Enters into a Strategic Collaboration with Hologen AI to Expedite Phase 3 Development of AAV-GAD for Parkinson’s Disease and Industrialize MeiraGTx’s Proprietary Manufacturing Process
- MeiraGTx to receive $200 million in upfront cash consideration - MeiraGTx and Hologen will form a joint venture, Hologen Neuro AI Ltd, with an additional $230 million committed capital from Hologen to fund 100% of the development of AAV-GAD for Parkinson …

Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that its Board of Directors has unanimously adopted a limited duration stockholder rights agreement (the “Rights Agreement”) to protect …

Jeffs’ Brands Achieves an Important Milestone Towards Completion of Fort’s Proposed Merger with a Publicly Traded Company – Receives Valuation Report of Fort for Approximately US$11.6 - US$14.2 Million
Tel Aviv, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that further to its press release dated …

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update
FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) Assuming FDA approval, proposed launch in PSVT targeted for mid-2025 Milestone well-capitalized to commercialize upon …

Carbon Nanotubes Market Size to Reach a Worth US$ 18.01 Billion by 2031 | Exclusive Report by The Insight Partners
US …

Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update
Achieves alignment with U.S. Food and Drug Administration (FDA) on regulatory path for potential accelerated approval of iopofosine I 131 as a treatment for Waldenström macroglobulinemia (WM) Evaluating timing for Phase 1 solid tumor studies; Auger- …

United Development Funding IV Announces Pre-Closing Cash Distribution Prior to Ready Capital Merger Closing
IRVING, Texas, March 13, 2025 (GLOBE NEWSWIRE) -- United Development Funding IV (“UDF IV”) announced today that on March 4, 2025, its board of trustees authorized a cash distribution of $2.3785 per share payable on or around March 13, 2025, to shareholders …

Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates
– Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer’s Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 – – On track to report final analysis from IGNITE Phase 2 clinical trial …

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update
AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional potential milestones of up to about $2.1 billion plus …

Wearable Devices Ltd. Announces 1-for-4 Reverse Stock Split
YOKNEAM ILLIT, ISRAEL, March 13, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI")-powered touchless sensing wearables, …

10th Annual BlueCherry Global Supply Chain & Technology Report: AI Insights and Merchandise Demand Planning Top Priorities for Fashion and Apparel Brands
NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Computer Generated Solutions, Inc. (CGS), a leading global provider of supply chain management software solutions for fashion businesses through its BlueCherry® platform, today released its 10th annual …

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results
The number of single-use handpiece units shipped in Q4 2024 exceeded expectations, increasing 5% overall and 20% in the U.S. compared to the same period last year Submitted a 510(k) premarket notification to the U.S. FDA for the AYON™ Body Contouring …

NexGold Provides Positive Update on Tailings Design for Feasibility Study at Goliath Gold Complex
TORONTO, March 13, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to announce certain potential positive outcomes as it works towards the completion of its Feasibility Study (the “FS”) for …

Village Farms International Reports Q4 and Full Year 2024 Results and Comments on Profitable Growth Initiatives in 2025
Full Year 2024 and Recent Business Highlights Full Year Consolidated Sales Grew 18% Year-over-Year to $336.2 Million 2024 Canadian Cannabis Sales Grew 31% Year-over-Year; Retail Branded Sales Grew 23% #1 Market Share in Dried Flower, #2 in Pre-Rolls, and # …

Dorman releases more Dorman® OE FIX™ auto repair innovations and dozens of first-to-the-aftermarket solutions
COLMAR, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (NASDAQ:DORM) is announcing the release of 164 new automotive repair solutions this month for its Light Duty segment. Almost half of the new components and assemblies are aftermarket …

Lifetime Brands, Inc. Reports Fourth Quarter 2024 Financial Results
Delivers Fourth Quarter Sales of $215 Million, a 6% Increase YoY TTM Adjusted EBITDA of $55.4 Million Launches Project Concord: Focus on International Business Turnaround to Accelerate Global Growth Declares Regular Quarterly Dividend GARDEN CITY, N.Y., …

Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream infections (BSIs) at day 30 post-HSCT; Company expects to …

GURU Organic Energy Reports Record Q1 2025 Performance with Strong Margin Expansion and Improved Profitability
Key Highlights: Best Q1 in GURU’s History: Net revenue up 8% to $7.7 million, driven by U.S. sales. Continued U.S. Sales Momentum: U.S. sales increased 46% to $2.1 million, reflecting higher sales velocity and innovation success. Strong Margin Expansion: …

Cartesian Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in Descartes-08-treated participants in Phase 2b trial Phase 2 trial of Descartes-08 in systemic lupus …